Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 832 results for "Novartis Company"

Sandoz strengthens its biosimilars portfolio with acquisition of Pfizer's biosimilar infliximab in E

EMA Accepts Application for Biosimilar Pegfilgrastim

​Sandoz, a Novartis company and the global leader in biosimilars, announced today that the European Medicines Agency (EMA) has accepted their Marketing Authorization Application (MAA) for its biosimilar to Amgen's EU-licensed ... MyInforms, 2 days ago

29 images for Novartis Company

Irish Times, 2 weeks ago
Drug Discovery and Development, 2 days ago
Reuters India, 2 weeks ago
Nasdaq, 3 days ago
Business Insider, 2 weeks ago
Sify, 2 weeks ago
Reuters UK, 2 weeks ago
Yahoo! Maktoob News, 2 weeks ago
Yahoo! Singapore, 2 weeks ago
Business Insider, 2 weeks ago
NDTV Profit

Novartis India posts Rs 60 cr net profit

Novartis India today reported a net profit of Rs 59.81 crore for the third quarter ended December 31, 2015. The company had posted a net loss of Rs 1.18 crore in the same period last fiscal, Novartis India said in a BSE filing. Net sales during the period ...
 Business Line3 days ago Novartis India Q3 net at Rs 60 cr  Moneycontrol.com3 days ago Extra ordinary income pushes Novartis profit to Rs. 60 cr in Q3  PharmaBiz2 days ago Novartis India Q3 net at Rs 60 crore  Economic Times3 days ago
Business Insider UK

A giant drugmaker is going to let insurers pay for heart medication based on how well it works

A Novartis logo is pictured on its headquarters building in Mumbai See Also Martin Shkreli's former company had a $23,000 yacht party while claiming it was losing money Drugmakers are using this ad campaign to fight Washington on a ...
 Business Insider UK4 days ago Novartis sets heart price drug with two insurers based on health outcome  Pharmacist.com4 days ago Insurers set performance-based price for heart drug  Formulary Journal4 days ago Cigna makes performance-based drug pricing deal with Novartis  FierceHealthPayer5 days ago

Novartis India: Outcome of board meeting

Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2016, inter alia, took on record the resignation of Ms. Manisha Girotra as Independent Director of the Company w.e.f. February 11, 2016.
 Money Control3 days ago Independent Director Ms. Manisha Girotra resigns from Novartis India Ltd  Equity Bulls2 days ago

BRIEF-Denmarks ISS says expands partnership with Novartis

Feb 10 Danish ISS A/S * Says expands and extends partnership with global pharmaceutical company Novartis * Says expands partnership to cover all sites across 24 countries in Europe * Says contract has been extended to run for an ...
 Reuters UK4 days ago Denmark's ISS says expands partnership with Novartis  Pharma Focus Asia4 days ago NOVARTIS : Sandoz Canada Expands Its Cancer Medication Portfolio With the Launch of (PR)Oxaliplatin Injection  4 Traders1 week ago
Jutia Group

Market Update: Cigna Corp (NYSE:CI) Cigna Implements Value-Based Contract with Novartis for Heart Drug EntrestoTM

at 09:35 AM EST [Business Wire] Cigna has entered into an outcomes-based contract with the pharmaceutical company Novartis for the drug Entresto, which was approved by the U.S. Food and Drug Administration for the treatment of heart failure with ...
 MoneyShow.com6 days ago Cigna Implements Value-Based Contract with Novartis for Heart Drug EntrestoTM  CNBC6 days ago CIGNA : Implements Value-Based Contract with Novartis for Heart Drug EntrestoTM  4 Traders6 days ago CIGNA Corporation Implements Value-Based Contract With Novartis AG For Heart Drug Entrestotm  BioSpace6 days ago
Hindustan Times

Novartis Prepares for "Explosion" of Gleevec Copycats

Novartis has forecast losing around $2.5 billion of its annual sales when companies rush on board to market generic versions of cancer wonder drug Gleevec later this year. The first generic copy of Gleevec was launched in the US this week by Sun ...
 PharmExec.com1 week ago Novartis braces for $2.5-billion hit from Gleevec copies  Hindustan Times1 week ago

NOVARTIS : Profit drop ; companies today

Drugmaker GLAXOSMITHKLINE posted a drop in annual profits yesterday after rising vaccine and consumer healthcare sales failed to offset falls at its key pharmaceutical unit. Core operating profit last year fell by 13% to Pounds 5.73bn compared with ...
 4 Traders1 week ago Novartis net profit up 73% on asset sale  DNA2 weeks ago Asset sales pump up Novartis profits  Money Control2 weeks ago
India Infoline

Rhizen-Novartis license agreement; Alembic Pharma ends higher

The company’s Swiss subsidiary Rhizen Pharmaceuticals S.A. entered into an exclusive, worldwide license agreement with Novartis for the development and commercialization of Rhizen's, inhaled dual Pl3K-delta gamma inhibitor and its closely related compounds ...
 India Infoline2 months ago Pact prop for Alembic Pharma  The Telegraph2 months ago

Novartis, Lupin, Pfizer and other drugmakers adopt ‘benching’ model to address attrition

HYDERABAD: Alarmed by attrition rates as high as 25 per cent, several drug makers in India, both local companies and multinationals with operations here, are devising novel 'benching' models to manage employee turnover. These firms are increasingly joining ...
 Economic Times2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less